Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome
Abstract Robust and accessible biomarkers that can capture the heterogeneity of Alzheimer’s disease and its diverse pathological processes are urgently needed. Here, we undertook an investigation of Alzheimer’s disease cerebrospinal fluid (CSF) and plasma from the same subjects (n=18 control, n=18 A...
Main Authors: | Eric B. Dammer, Lingyan Ping, Duc M. Duong, Erica S. Modeste, Nicholas T. Seyfried, James J. Lah, Allan I. Levey, Erik C. B. Johnson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Alzheimer’s Research & Therapy |
Online Access: | https://doi.org/10.1186/s13195-022-01113-5 |
Similar Items
-
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
by: Erica S. Modeste, et al.
Published: (2023-07-01) -
Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease
by: Caroline M. Watson, et al.
Published: (2023-05-01) -
Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer’s Disease
by: Lenora Higginbotham, et al.
Published: (2019-08-01) -
Correction to: Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer’s disease
by: Laura E. Donovan, et al.
Published: (2021-05-01) -
Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease
by: Jingting Dai, et al.
Published: (2018-12-01)